"I am glad that taking part in a trial might help others on their own cancer journey.”
A study looking at how often people being treated for myeloma have a very low number of white blood cells
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
This study looked at how often people being treated with lenalidomide and dexamethasone for myeloma have a very low number of white blood cells (neutropenia).
More about this trial
- how many people had a drop in white blood cells
- how doctors usually treat it
Summary of results
- 62 people (31%) had a low white blood cell count at least once during treatment
- half of these people had a low white blood cell count 3 times or more
- the drop in white blood cells usually happened about 2 months (8.8 weeks) after starting treatment
- whose kidneys didn’t work as well as normal
- whose myeloma was more advanced
- who were generally less fit and well
- who had other medical conditions
How to join a clinical trial